Morton Kanter Schwartz

Morton Kanter Schwartz's AcademicInfluence.com Rankings

Philosophy

#7777

World Rank

#11032

Historical Rank

Logic

#4814

World Rank

#6143

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Morton Kanter Schwartz's Degrees

Doctorate Medicine University of California, San Francisco

Why Is Morton Kanter Schwartz Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Morton Kanter Schwartz's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. (1978) (470)
Inhibition of leukemias in man by L-asparaginase. (1967) (306)
Toxicity of E. coli L‐asparaginase in man (1970) (287)
Role of trace elements in cancer. (1975) (251)
Alphafetoprotein and human chorionic gonadotropin determination in cerebrospinal fluid. An aid to the diagnosis and management of intracranial germ-cell tumors. (1979) (198)
Pathological review of breast lesions analyzed for estrogen receptor protein. (1975) (195)
Flow cytometry of breast carcinoma: I. Relation of DNA ploidy level to histology and estrogen receptor (1981) (175)
Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection (1990) (158)
Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer. (2000) (144)
Partial purification of a serum factor that causes necrosis of tumors. (1976) (138)
Serum HER2 extracellular domain in metastatic breast cancer patients treated with weekly trastuzumab and paclitaxel: association with HER2 status by immunohistochemistry and fluorescence in situ hybridization and with response rate. (2005) (129)
Use of CEA as an indicator of early recurrence and as a guide to a selected second-look procedure in patients with colorectal cancer. (1978) (127)
Corynebacterium parvum as the priming agent in the production of tumor necrosis factor in the mouse. (1977) (113)
Estrone and estradiol content in human breast tumors: relationship to estradiol receptors. (1977) (109)
Glutathione metabolism in newborns: Evidence for glutathione deficiency in plasma, bronchoalveolar lavage fluid, and lymphocytes in prematures (1995) (108)
Cerebrospinal fluid biochemical markers of central nervous system metastases (1980) (108)
Estrogen and progesterone receptors in breast carcinoma: Correlations with epidemiology and pathology (1981) (106)
Steroid hormone accumulation in human breast cyst fluid. (1981) (103)
Carcinoembryonic antigen: its role as a marker in the management of cancer. A National Institutes of Health Consensus Development Conference. (1981) (103)
Cerebrospinal fluid (β2-microglobulin in patients with AIDS dementia complex: an expanded series including response to zidovudine treatment (1992) (98)
The value of diagnostic aids in detecting pancreas cancer (1978) (93)
Comparative analysis of complexed prostate specific antigen, free prostate specific antigen and their ratio in detecting prostate cancer. (2002) (92)
COMPARATIVE EFFECTS OF L-HISTIDINE ON THE ACTIVITIES OF 5'-NUCLEOTIDASE AND ALKALINE PHOSPHATASE. (1963) (91)
A preliminary evaluation of tissue polypeptide antigen in serum or urine (or both) of patients with cancer or benign neoplasms. (1978) (90)
Estrogen receptor protein (ERP) in multiple tumor specimens from individual patients with breast cancer (1977) (88)
Clinical utility of serum HER-2/neu testing on the Bayer Immuno 1 automated system in breast cancer. (2001) (80)
Tissue cathepsins as tumor markers. (1995) (75)
Enzymes in cancer. (1973) (74)
Solving the problem of antibody interference in commercial "sandwich"-type immunoassays of carcinoembryonic antigen. (1989) (66)
CA 15-3 and carcinoembryonic antigen in the clinical evaluation of breast cancer. (1991) (60)
L‐asparaginase activity in plasma and other biological fluids (1970) (58)
Dietary Zinc Deficiency Decreases Plasma Concentrations of Vitamin E 1 (1989) (57)
Genetic testing and the clinical laboratory improvement amendments of 1988: present and future. (1999) (56)
CEA (carcinoembryonic antigen): Its role as a marker in the management of cancer (2004) (56)
Correlation between estrogen receptor protein and carcinoembryonic antigen in normal and carcinomatous human breast tissue. (1976) (55)
Monitoring Therapy by Serum HER-2/Neu (2000) (55)
Abnormally high concentrations of beta 2 microglobulin in acquired immunodeficiency syndrome (AIDS) patients. (1983) (52)
Serum 5′‐nucleotidase in patients with cancer (1965) (52)
[55] Lactic dehydrogenase (clinical aspects) (1966) (52)
Accumulation of hormones in breast cyst fluid. (1979) (51)
Procedure for staining zones of activity of glutamic oxaloacetic transaminase following electrophoresis with starch gel. (1963) (50)
Enzymes as prognostic markers and therapeutic indicators in patients with cancer. (1992) (50)
Beta 2-microglobulin as a prognostic marker for development of AIDS. (1985) (50)
Plasma lipid-bound sialic acid and carcinoembryonic antigen in cancer patients. (1981) (48)
Cerebrospinal fluid biochemical markers in central nervous system tumors: a review. (1981) (47)
Accuracy of Fecal Occult Blood Test Interpretation (1991) (45)
Evaluation of CA M26, CA M29, CA 15-3 and CEA as circulating tumor markers in breast cancer patients. (1991) (45)
Effect of tamoxifen on serum cholesterol and lipoproteins during chemohormonal therapy. (1993) (42)
Automated assay of activities of enzymes involving the diphosphopyridine nucleotide-reduced diphosphopyridine nucleotide reaction. (1961) (40)
Interferences in diagnostic biochemical procedures. (1973) (39)
Cation levels in human breast cyst fluid. (1981) (37)
Strategies of organization and service for the critical-care laboratory. (1990) (37)
Abbott IMx evaluated for assay of prostate-specific antigen in serum. (1992) (36)
L-2-oxothiazolidine-4-carboxylate, a cysteine precursor, stimulates growth and normalizes tissue glutathione concentrations in rats fed a sulfur amino acid-deficient diet. (1995) (34)
Carcinoembryonic antigen in colonic lavage. (1977) (34)
Estrogen receptor protein of breast cancer in patients with positive nodes. High recurrence rates in the postmenopausal estrogen receptor-negative group. (1987) (31)
Enzymes in cancer. (1989) (30)
Roche RIA and Abbott EIA carcinoembryonic antigen assays compared. (1984) (30)
Acid phosphatases; a review. (1954) (30)
CEA-like material in fluid from benign cysts of the breast. (1974) (29)
[261c] Clinical aspects of aspartate and alanine aminotransferases☆☆☆★ (1971) (29)
Selective inhibition of terminal deoxynucleotidyl transferase (TdT) by adenosine ribonucleoside triphosphate (ATP) and its application in the detection of TdT in human leukemia. (1977) (28)
Automated approaches to rapid-response testing. A comparative evaluation of point-of-care and centralized laboratory testing. (1995) (28)
Metabolism in surgical patients. I. Nitrogen metabolism in totally gastrectomized patients. (1956) (28)
AUTOMATED METHODS FOR DETERMINATION OF ENZYME ACTIVITY. (1963) (27)
Infectious hepatitis; correlation of clinical and laboratory findings, including serum enzyme changes. (1959) (27)
Lactic dehydrogenase. An old enzyme reborn as a cancer marker? (1991) (26)
The false-negative hemoccult test. (1977) (26)
PROPERTIES OF ACTIVITY OF 5'-NUCLEOTIDASE IN HUMAN SERUM, AND APPLICATIONS IN DIAGNOSIS. (1964) (24)
CLINICAL APPLICATION OF PHOSPHOHYDROLASE MEASUREMENTS IN CANCER * (1969) (24)
Plasma lipid bound sialic acid in patients with prostate and bladder cancer. (1981) (24)
Polyinosinic-Polycytidylic Acid Toxicity (1971) (24)
Urinary cystathionine, catecholamine, and metabolites in patients with neuroblastoma. (1972) (24)
Comparison of serum alkaline phosphatase activities determined with sodium beta-glycerophosphate and sodium phenylphosphate as substrates. (1960) (23)
International Federation of Clinical Chemistry, Education Committee and International Union of Pure and Applied Chemistry, Division of Clinical Chemistry: definition of the terms certification, licensure and accreditation in clinical chemistry. (1985) (23)
Relationship of the electrophoretic patterns of phosphohexose isomerase and glutamic oxyaloacetic transaminase in human tissues to the patterns in serum of patients with neoplastic disease. (1966) (22)
Lipid-bound sialic acid as a tumor marker. (1983) (21)
Isozymes of aspartate aminotransferase in tissues and blood of man. (1966) (21)
CA 549 as a Marker in Breast Cancer (1991) (20)
Regenerative Hyperplasia of the Liver Following Major Hepatectomy: Chemical Analysis of the Regenerated Liver and Comparative Nuclear Counts (1959) (19)
Lactic acid dehydrogenase during pregnancy and puerperium. (1959) (19)
Glucosephosphate isomerase as a CSF marker for leptomeningeal metastasis (1991) (19)
(Washington University Case Conference). Colorectal carcinoma and carcinoembryonic antigen (CEA). (1980) (19)
Fat and nitrogen metabolism in patients with massive small bowel resections. (1956) (18)
Murine mammary tumor virus related antigen in human male mammary carcinoma (1983) (18)
Chemical and clinical evaluation of the continuous-flow analyzer "SMAC". (1974) (17)
The clinical utility of plasma and urinary carcinoembryonic antigen in patients with genitourinary disease. (1977) (17)
Barr body distribution and estrogen receptor protein in mammary carcinoma. (1977) (17)
Metabolism in surgical patients. II. Fat and mineral metabolism in totally gastrectomized patients. (1956) (17)
Measurement of carcinoembryonic antigen. (1973) (16)
Two whole-blood multi-analyte analyzers evaluated. (1989) (16)
Measurement of the estradiol receptor in human breast tissue by the immobilized antibody method. (1975) (16)
Multicenter Evaluation of the Performance and Clinical Utility in Longitudinal Monitoring of the Bayer Immuno 1™ Complexed PSA Assay (1999) (16)
Enzymes used in predicting high risk to colon cancer. (1990) (16)
Effect of phosphate in enhancing the action of triiodothyronine. (1956) (15)
Studies of the physiology of the dumping syndrome. (1955) (15)
Cerebrospinal fluid beta 2 microglobulin in patients infected with human immunodeficiency virus. (1989) (15)
The effect of a gluten-free diet on fat, nitrogen, and mineral metabolism in patients with sprue. (1957) (15)
Utilization of automation for studies of enzyme kinetics. (1968) (15)
Diagnostic biochemical methods in pancreatic disease. (1970) (15)
Accuracy of fecal occult blood test interpretation. National Polyp Study Work Group. (1991) (15)
Serum Adenosine Deaminase Activity in Cancer.† (1959) (14)
Detection of terminal deoxynucleotidyl transferase (TdT) by flow cytometry in leukemic disorders. (1989) (14)
Metastatic adrenal cortical carcinoma: biochemical changes accompanying clinical regression during therapy with o,p'-DDD. (1971) (14)
Variation in the quantitation of prostate-specific antigen in reference material: differences in commercial immunoassays. (1998) (14)
Serum relaxin and human chorionic gonadotropin concentrations in spontaneous abortions. (1981) (13)
Current status of tumour markers. (1995) (13)
Bayer immuno 1™ PSA assay: An automated, ultrasensitive method to quantitate total PSA in serum (1998) (13)
Sulfur amino acid metabolism in hepatobiliary disorders. (1992) (13)
Comparison of activities of isocitric dehydrogenase and glutamic-oxalacetic transaminase in serum infectious hepatitis. (1960) (13)
Problems in the interpretation of serum cholesterol values. (1972) (13)
Comparison of Roche RIA, Roche EIA, Hybritech EIA, and Abbott EIA methods for measuring carcinoembryonic antigen. (1988) (12)
Chemical and clinical evaluation of the random access analyzer "RA-1000". (1984) (12)
Automated flame photometry of serum sodium and potassium. (1971) (12)
AUTOMATION OF ENZYME DETERMINATIONS: PHOSPHOHEXOSE ISOMERASE * (1960) (11)
Carcinoembryonic antigen in children with neuroblastoma. (1976) (11)
Automated method for determination of serum 5'-nucleotidase activity. (1972) (11)
An automated, fluorometric procedure for determining serum lipase. (1971) (11)
Alkaline and acid phosphatases. (1961) (11)
Metabolism in surgical patients. III. Effect of drugs and dietary procedures on fat and nitrogen metabolism in totally gastrectomized patients. (1956) (10)
Evaluation of HPLC column performance for clinical studies. (1985) (10)
The action of acid phosphatase from cancerous and noncancerous human prostate on various substrates (1953) (10)
Glycolytic and related enzymes. (1961) (10)
Cerebrospinal fluid biochemical markers of central nervous system metastasis. (1978) (9)
Breast cancer marker Ca549. A multicenter study. (1994) (9)
CEA in colonic lavage of individuals at high risk for large bowel cancer (1978) (9)
Biochemistry of malignant melanoma. (1976) (9)
pH as a marker of breast cyst fluid biochemical type. (1987) (9)
[99] Phosphohexose isomerase: Clinical aspects (1966) (9)
Comparison of carcinoembryonic antigen (CEA) methodologies. (1974) (8)
Neuron-specific enolase and retinoblastoma. Clinicopathologic correlations. (1989) (8)
International Federation of Clinical Chemistry (IFCC), Education Committee and International Union of Pure and Applied Chemistry. Guidelines (1985) for teaching of clinical chemistry to medical students. (1985) (8)
Enzyme patterns in cancer. (1977) (8)
Estrogen and progesterone receptor proteins in patients with breast cancer. (1993) (8)
Enzyme tests in cancer. (1982) (7)
Urinary lactic dehydrogenase in genitourinary tract diseases. (1969) (7)
Use of evacuated collection tubes for routine determination of arterial blood gases and pH. (1971) (7)
A basic education and training framework for medical laboratory technicians in clinical chemistry (1984) (7)
Plasma Proteins in Health and Disease (1963) (7)
Argument in favor of using mass units to calibrate and report concentrations of human choriogonadotropin. (1986) (6)
Screening for cancer: is it cost effective? (1993) (5)
USE OF COMMERCIALLY AVAILABLE PREPARATIONS OF FRUCTOSE 6-PHOSPHATE IN THE DETERMINATION OF PHOSPHOHEXOSE ISOMERASE ACTIVITY. (1965) (5)
SERUM BILE ACIDS IN PATIENTS WITH LIVER DISEASE. (1965) (5)
Biochemical procedures as aids in diagnosis of different forms of cancer. (1974) (5)
Changes in serum alpha-fetoprotein and chorionic gonadotropin in response to cancer therapy. (1984) (5)
Multicenter evaluation of the Bayer Immuno I CA 15-3 assay. (1998) (5)
Cystathionine excess in children with hepatic cancer. (1973) (5)
[2] Automated enzyme analysis-general (1971) (4)
Measurement of anti-folate analogs. (1992) (4)
Effect of 5-dydroxyindolylacetic acid in the colorimetric determination of urinary vanilmandelic acid. (1969) (4)
Solid-phase enzyme immunoassay of terminal deoxynucleotidyl transferase evaluated. (1987) (4)
The distribution and clearance of L-asparaginase. (1970) (4)
Effects and concentrations of L-asparagin-ase in intracerebrally inoculated leukemia. (1968) (4)
The role of the laboratory in the prevention and detection of chronic disease. (1992) (4)
TUMOR MARKERS IN THE PATIENT WITH LUNG CANCER (1987) (4)
Tumor markers: what is their role? (1990) (4)
Circulating and tissue markers in the longitudinal management of breast cancer patients. (1994) (4)
Clinical chemistry : trace metals (1991) (3)
Clinical evaluation of the VMA test strip. (1973) (3)
Laboratory diagnosis for cancer: a look at the future. (1978) (3)
Effect of storage in deep freeze upon activity of urinary acid phosphatase. (1956) (3)
Estrogen receptor protein in visceral metastases from breast carcinoma. (1981) (3)
Recent advances in calcium and phosphorus metabolism. (1975) (3)
Guidelines (1985) for clinical chemists for effective communication of clinical chemistry laboratory data. IFCC Document Stage 2, Draft 3. (1986) (3)
Preclinical determination of AIDS disease by a series of tests. (1986) (3)
Measurement of 5′-Nucleotidase Activity in Serum (1972) (3)
Cerebrospinal fluid markers in central nervous system metastases from testicular carcinoma. (1979) (3)
International Federation of Clinical Chemistry, Education Committee: and International Union of Pure and Applied Chemistry, Division of Clinical Chemistry: guidelines (1985) for clinical chemists for effective communication of clinical chemistry laboratory data. (1985) (2)
Biochemical procedures in different forms of cancer. (1971) (2)
Blood groups and response to therapy for mammary cancer. (1977) (2)
Prostatic Specific Antigen, Prostatic Acid Phosphatase and Acid Phosphatase in Patients with Prostate Cancer and Benign Prostatic Hyperplasia (1987) (2)
Placental alterations in toxemia of pregnancy in the guinea pig. (1958) (2)
Advances in the use of tumor markers. (1990) (2)
Comparison of assays for prostatic and total acid phosphatase. (1990) (2)
Performance evaluation of a blood gas system in a central and satellite laboratory. (1979) (2)
Immunoassay of enzymes--an overview. (1983) (2)
Biochemical Markers in Cancer (1981) (2)
14. Lung Cancer (1987) (2)
[261a] Clinical aspects of arginase☆☆☆ (1971) (2)
Stac sequential test analyzer with computer an initial evaluation (1978) (1)
Post-doctoral training of the non-physician doctoral scientist. (1994) (1)
Biochemical and immunologic diagnosis of cancer. Germ cell tumors. (1987) (1)
66 Aminoglutethimide as late treatment of metastatic breast cancer (1983) (1)
Estrogen binding and estrogen receptor activity in the human prostate: a preliminary report. (1981) (1)
GOT and GPT, Assay with Automatic Analysers* (1974) (1)
Relevance of steroid receptor measurements in the diagnosis and therapeutic management of cancer patients. (1979) (1)
Hormone analysis: bioassay and immunochemical methodology. (1975) (1)
Book ReviewGradwohl's Clinical Laboratory Methods and Diagnosis. Vols. 1 and 2. (1981) (1)
Biochemical and immunologic diagnosis of cancer. Lung cancer. (1987) (1)
Introduction to Technology Section (1983) (1)
The two stage provocative test for pancreatic disease by serum enzyme measurements. (1980) (1)
Consensus Report, 1987 (1987) (1)
Observations on serum enzyme alterations in experimental renal ischemia. (1973) (1)
Fecal Occult Blood Screening Tests (1986) (1)
Detection of Tumor-Associated Antigens in Plasma or Serum (1976) (1)
Vegetable peroxidase inhibitor--an improvement in the guaiac fecal occult blood test. (1985) (1)
Monographs on Endocrinology 7: Prostaglandins. E. W. Horton. Springer-Verlag, New York, Inc., 175 Fifth Avenue, New York, N. Y. 10010, 1972, xi + 197 pp. $18.20 (1972) (1)
Tumour markers, enzymes and hormonal markers. (1976) (0)
State of the art in automated analysis. (1974) (0)
The Increase of Thyroid Abnormalities, Elevated Serum Beta Globulins and Type A Blood Group in Paget's Disease. (1966) (0)
UrinaryCystathionine, Catecholamine, and Metabolites in Patients withNeuroblastoma (1972) (0)
An evaluation of a non-isotopic homogeneous enzyme immunoassay (CEDIA assay) for cortisol and its clinical utility. (1992) (0)
Estrogen receptors and tumor associated antigens in breast cancer. (1979) (0)
Definition of the terms certification, licensure and accreditation in clinical chemistry. IFCC Document Stage 2, Draft 3. (1986) (0)
[261b] Clinical aspects of l-asparaginase☆☆☆ (1971) (0)
Bone tumors. (1990) (0)
Acute-phase reactants as tumor markers. (1995) (0)
Solid-Phase EnzymeImmunoassay ofTerminalDeoxynucleotidyl Transferase Evaluated (1987) (0)
Biochemistry of Human Cancer. O. Bodansky. Academic Press, New York, N. Y. 10003, 1975, xiv + 657 pp. $39.50 (1975) (0)
Cancer Markers: Diagnostic and Developmental Significance. S. Sell, Ed. The Humana Press, Inc., Clifton, NJ 07015. xxvii + 541 pp. Pub. Jan. 1980. $49.50 (1980) (0)
A review of methodology for estrogen and progesterone receptor protein analysis. (1992) (0)
Solvingthe Problemof AntibodyInterferencein Commercial “ Sandwich ”-TypeImmunoassays of CarcinoembryonicAntigen (2004) (0)
Substate specificity of phosphatase (1952) (0)
DeterminingSerum Lipase (2004) (0)
Automation and Data Processing in the Clinical Laboratory. G. M. Brittin and M. Werner, Eds. Charles C Thomas, Springfield, Ill. 1970, x + 174 pp. $13.50 (1970) (0)
Sex Hormones in Patients with Benign Prostatic Hyperplasia: A Comparison of Prostate Volume with Steroid Hormone Levels (1987) (0)
Timor Antigens and Other Tumor Markers: Their Effectiveness in Cancer Diagnosis (1982) (0)
Biochemical and immunochemical markers associated with cancer. (1976) (0)
Procedure for examination of brystcystevaeske the risk of cancer (1985) (0)
The real world--regulations and ethics. (1992) (0)
Metastatic AdrenalCorticalCarci noma:Biochemical Changes Accompanying ClinicalRegression DuringTherapy with01p'-DDD' (1971) (0)
Observations on serum enzyme alterations in experimental renal ischemia. (1973) (0)
Breast cancer: alternative therapy. Hormone receptor assay. (1977) (0)
Oxaloacetic Transaminase in Human Tissues to the Patterns in Serum of Patients with Neoplastic Disease (1966) (0)
Advances in Enzymology, 39. A. Meister, Ed., John Wiley & Sons, New York, N. Y. 10016, 1973, v + 487 pp. $22.50 (1974) (0)
The determination of quinidine in blood (1949) (0)
Trlclonai Gammopathy In a Patient (2000) (0)
Routine use of beta 2-microglobulin assays. (1987) (0)
Biochemical Characteristics of 5′-Nucleotidase and Diagnostic Utilization of Its Activity in Human Serum. (1967) (0)
The effect of a gluten-free diet on fat, nitrogen, and mineral metabolism in patients with sprue. (1968) (0)
Vitamins and Coenzymes. Vol. XVIII. Part A. Methods in Enzymology. D.B. McCormick and L.D. Wright, Eds., Academic Press, Inc., 111 Fifth Ave., New York, N. Y. 10003. 1970, xxi + 688 pp. $29.50 (1971) (0)
How do we detect hereditary large bowel cancer? Biochemical diagnosis. (1983) (0)
Human tumor markers : proceedings of the International Symposium on Human Tumor Markers held in Taipei, Taiwan, R.O.C., 3-5 September 1988 (1989) (0)
Direct RadloImmunoassay of MelatonlnIn Saliva (2004) (0)
Section Meeting on Early Diagnosis, Prevention, and Human Genetics (1974) (0)
In Reply: Phosphohexose Isomerase In Lung Cancer (1988) (0)
Comparisonof Roche RIA , Roche EIA , HybritechEIA , and Abbott EIA Methodsfor Measunng CarcinoembryonicAntigen (2004) (0)
Vitamins and Coenzymes, XVIII, Part C, Methods in Enzymology. D. B. McCormick and L. D. Wright, Eds. Academic Press, Inc., New York, N. Y. 10003, 1971, xviii + 786 pp. $32.00 (1972) (0)
Book Review Interpretation of Protein and Isoenzyme Patterns in Body Fluids By Tsieh Sun. 255 pp., illustrated. New York, Igaku—Shoin, 1991. $69.50. (1992) (0)
Hormone Receptor Assay (1977) (0)
Reply of the authors: Hemoccult Testing (1977) (0)
Book Review:Alpha-Fetoprotein and Hepatoma. Hidematsu Hirai, Toru Miyaji (1974) (0)
Variation in the Quantitation of Prostate-specific Anti- gen in Reference Material: Differences in Commercial (1998) (0)
Measurementof Total Alkaline PhosphataseActivityin HumanSerum (1988) (0)
Biochemistry: Practical Clinical Enzymology . By J. King. Van Nostrand, Princeton, N.J., 1965. 363 pp., $12.50. (1966) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Morton Kanter Schwartz?

Morton Kanter Schwartz is affiliated with the following schools:

New York University